Escugen Biotechnology | ApexOnco - Clinical Trials news and analysis

“It's very intuitive and always up-to-date”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Conferences Trial results

22 July 2024

Early attention falls on ADCs originated by ProfoundBio, SystImmune, MediLink and Seagen.

Conferences Trial results

10 December 2023

Recent Quick take